Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mohammed Jasim Jawad"'
Autor:
Eman Jawad Jabber, Asawer Mhammed Alzayd, Mohammed Jasim Jawad, Ihsan Mohammed Sulbi, Saif Mohammed Hassan, Mahmood Jasim Jawad, Adnan Mansour Jasim
Publikováno v:
Brazilian Journal of Veterinary Research and Animal Science, Vol 59 (2022)
In breast cancer treatment, chemotherapy resistance is a major problem where many receptive tumors rebound and develop resistance. When provided in combination, cancer drugs are most successful, thus reducing the risk of developing resistant cancer c
Externí odkaz:
https://doaj.org/article/25e9d3aa33024596aebdcb3d20397710
Autor:
Mohammed Jasim Jawad, Alan Richardson
Publikováno v:
Diseases, Vol 11, Iss 1, p 49 (2023)
We have previously shown that pitavastatin has the potential to be used to treat ovarian cancer, although relatively high doses are likely to be necessary. One solution to this problem is to identify drugs that are synergistic with pitavastatin, ther
Externí odkaz:
https://doaj.org/article/48e7d68bef584d2d821084ad53dbfdb8
Autor:
Eman Jawad Jabber, Asawer Mhammed Alzayd, Mohammed Jasim Jawad, Ihsan Mohammed Sulbi, Saif Mohammed Hassan, Mahmood Jasim Jawad, Adnan Mansour Jasim
Publikováno v:
Brazilian Journal of Veterinary Research and Animal Science; Vol. 59 (2022); e191527
Brazilian Journal of Veterinary Research and Animal Science; v. 59 (2022); e191527
Brazilian Journal of Veterinary Research and Animal Science; V. 59 (2022); e191527
Brazilian Journal of Veterinary Research and Animal Science
Faculdade de Medicina Veterinária e Zootecnia da Universidade de São Paulo (FMVZ-USP)
instacron:USP
Brazilian Journal of Veterinary Research and Animal Science; v. 59 (2022); e191527
Brazilian Journal of Veterinary Research and Animal Science; V. 59 (2022); e191527
Brazilian Journal of Veterinary Research and Animal Science
Faculdade de Medicina Veterinária e Zootecnia da Universidade de São Paulo (FMVZ-USP)
instacron:USP
In breast cancer treatment, chemotherapy resistance is a major problem where many receptive tumors rebound and develop resistance. When provided in combination, cancer drugs are most successful, thus reducing the risk of developing resistant cancer c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49f06c07238cd86f2f079d74ff025ee7
https://www.revistas.usp.br/bjvras/article/view/191527
https://www.revistas.usp.br/bjvras/article/view/191527